<DOC>
<DOCNO>
EP-0002010
</DOCNO>
<TEXT>
<DATE>
19790530
</DATE>
<IPC-CLASSIFICATIONS>
A61P-9/04 C07D-409/12 C07D-491/00 C07D-209/48 C07D-409/00 <main>C07D-233/50</main> A61K-31/415 C07D-491/04 A61K-31/4168 C07C-335/40 C07D-405/00 C07C-335/00 A61K-31/4164 C07D-405/12 C07C-157/09 C07D-233/44 C07C-83/00 C07D-401/00 C07D-233/00 C07C-157/14 C07D-207/40 A61P-9/00 C07D-413/12 A61P-9/12 C07D-209/00 C07D-233/50 A61P-29/00 C07D-401/12 
</IPC-CLASSIFICATIONS>
<TITLE>
derivatives of 2-imino-imidazolidine, processes for their preparation, pharmaceutical compositions containing them and intermediates.
</TITLE>
<APPLICANT>
hoffmann la rochech<sep>f.hoffmann-la roche & co. aktiengesellschaft<sep>f. hoffmann-la roche &amp; co. aktiengesellschaftpostfach 32554002 baselch<sep>f. hoffmann-la roche & co. aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
ramuz henri dr<sep>ramuz, henri, dr.<sep>ramuz, henri, dr.rheinparkstrasse 3ch-4127 birsfeldench<sep>ramuz, henri, dr.<sep>ramuz, henri, dr.rheinparkstrasse 3ch-4127 birsfeldench<sep>
</INVENTOR>
<ABSTRACT>
New2-iMino imidazolidine derivatives are described with cardiovascular activity, in particular blood pressure lowering effect, the formula wherein R¹, R² and R³ independently of each other per hydrogen, alkyl, alkoxy, alkylthio, halogen, trifluoromethyl, cyano or hydroxy and R⁴ is hydrogen, alkyl, cycloalkyl, cyclo alkenyl, alkenyl, alkynyl, dialkylaminoalkyl, carboxyalkyl, carboxyalkenyl, hydroxyalkyl, cyanoalkyl, arylalkyl, alkyl thioalkyl, alkoxycarbonylalkyl, alkoxyalkoxyalkyl, amino alkyl, monoalkylaminocarbonylalkyl, dialkylamino carbonylalkyl, alkoxycarbonylalkenyl, alkoxyalkyl, amino alkyl, substituted aminoalkyl, aryl, (2.2 , 8-trimethyl-4H-m-dioxino [4,5-C] pyridine-5-yl) methyl, [5-hydroxy-4- (hy droxymethyl) -6-methyl-3-pyridyl] methyl, α-carboxybenzyl , α-alkoxycarbonyl-α-alkylphenyl or a one -CH (R⁵) group-bound, optionally substituted by alkyl or the group -COOR-substituted 5- or, given units by alkyl, alkoxy or the group -Coor subs Titiated 6-membered aromatic heterocyclic radical residue with one or two heteroatoms, wherein as heteroatoms, oxygen, nitrogen or sulfur in question and R⁵ is hydrogen, methyl, ethyl or n-propyl and R hydrogen or alkyl, pharmaceutically applicable acid addition salts thereof as well as methods for their Production; They are suitable for the treatment of hypertension.
</ABSTRACT>
</TEXT>
</DOC>
